FDA Announces Joint Meeting of Public Advisory Committees

Summary

The Food and Drug Administration (FDA) will hold a joint meeting of its Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee, which will be open to the public, to provide advice and recommendations on FDA's regulatory issues.